News

Aldeyra Therapeutics: Pivotal FDA Decision After Reproxalap's Chamber Data
Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...
Markets March On, Reality Not Included
The S&P and Nasdaq notched fresh record highs Wednesday, because apparently the best time to chase stocks is when jobs ...
HOOY: When Covered Calls Meet Robinhood's Volatility
The YieldMax HOOD Option Income Strategy ETF offers a covered call strategy on Robinhood. Click here to read why I rate HOOY ...